Event bio
6 – 7 May, 2026
Berlin
Join us at the 12th Annual Pharmaceutical Risk Management and Pharmacovigilance Summit, where industry leaders will address the most critical challenges shaping drug safety today. From AI-powered signal detection and automation in case processing to evolving global pharmacovigilance regulations and real-world evidence integration, this event delivers practical strategies for modern risk management.
Gain actionable insights into benefit-risk assessment, risk minimisation measures, inspection readiness, and cross-functional collaboration across medical, regulatory, and safety teams. Explore how digital transformation, data governance, and advanced analytics are redefining pharmacovigilance systems worldwide.
With exclusive networking opportunities, this summit is designed for senior executives, pharmacovigilance leaders, and regulatory professionals committed to ensuring patient safety while driving innovation in a rapidly evolving pharmaceutical landscape.
Join us at the 12th Annual Pharmaceutical Risk Management and Pharmacovigilance Summit, where industry leaders will address the most critical challenges shaping drug safety today. From AI-powered signal detection and automation in case processing to evolving global pharmacovigilance regulations and real-world evidence integration, this event delivers practical strategies for modern risk management.
Gain actionable insights into benefit-risk assessment, risk minimisation measures, inspection readiness, and cross-functional collaboration across medical, regulatory, and safety teams. Explore how digital transformation, data governance, and advanced analytics are redefining pharmacovigilance systems worldwide.
With exclusive networking opportunities, this summit is designed for senior executives, pharmacovigilance leaders, and regulatory professionals committed to ensuring patient safety while driving innovation in a rapidly evolving pharmaceutical landscape.
Who Should Attend
Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of Departments managers from pharma industry involved in:
- Pharmacovigilance
- Risk Management
- PV Monitoring
- Signal Detection
- Data Collection
- Safety Surveillance
- Safety Evaluation
- Patient Safety
- Drug Safety
- Benefit-Risk Evaluation
- Quality Assurance
- Compliance
- Reporting and Data Collection
- Compliance
- Signal Detection
- Pharmacovigilance Operations
- QPPV
- Benefit-risk Management
- PV Writing
- Inspections
- PV Governance
- Management Safety Data
- Lifecycle Management Quality
- Clinical Safety
Look at the Main Topics
Of Our Conference
- 01Inspection trends in 2026: What regulators now focus on first
- 02From document to living framework: Operationalising RMPs
- 03New expectations for signal detection timelines and documentation
- 04Metrics that matter: Beyond ICSR submission timelines
- 05Data integrity findings in PV: Lessons learned the hard way
- 06Cross-functional ownership: Who controls RWE in PV?
- 07Transparency in safety decision-making
- 08From operational execution to strategic safety leadership
